Construction and validation of nomograms to reduce completion thyroidectomy by predicting lymph node metastasis in low-risk papillary thyroid carcinoma

被引:6
作者
Wang, Rong [1 ]
Tang, Zimei [1 ]
Wu, Zhenghao [1 ]
Xiao, Yunxiao [1 ]
Li, Jiexiao [1 ]
Zhu, Junling [1 ]
Zhang, Ximeng [1 ]
Ming, Jie [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Breast & Thyroid Surg, 1277 Jiefang Ave, Wuhan 430022, Peoples R China
来源
EJSO | 2023年 / 49卷 / 08期
关键词
Papillary thyroid carcinoma; Completion thyroidectomy; Lymph node metastasis; Nomogram; ASSOCIATION GUIDELINES; RADIOACTIVE IODINE; YOUNG AGE; FOLLOW-UP; CANCER; RECURRENCE; SURVIVAL; NODULES; WELL; SIZE;
D O I
10.1016/j.ejso.2023.03.236
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Context: More than 5 central lymph nodes metastases (CLNM) or lateral lymph node metastasis (LLNM) indicates a higher risk of recurrence in low-risk papillary thyroid carcinoma (PTC) and may lead to completion thyroidectomy (CTx) in patients initially undergoing lobectomy. Objective: To screen potentially high-risk patients from low-risk patients by using preoperative and intraoperative clinicopathological features to predict lymph node status. Methods: A retrospective analysis of 8301 PTC patients in Wuhan Union Hospital database (2009e2021) was performed according to the 2015 American Thyroid Association (ATA) and 2021 National Comprehensive Cancer Network (NCCN) guidelines, respectively. Logistic regression and best subsets regression were used to identify risk factors. Nomograms were established and externally validated using the Differentiated Thyroid Cancer in China cohort. Results: More than 5 CLNM or LLNM was detected in 1648 (19.9%) patients. Two predictive models containing age, gender, maximum tumor size, free thyroxine (FT4) and palpable node (all p < 0.05) were established. The nomogram based on NCCN criteria showed better discriminative power and consistency with a specificity of 0.706 and a sensitivity of 0.725, and external validation indicated that 76% of potentially high-risk patients could achieve preoperative conversion of surgical strategy. Conclusions: Models based on large cohorts with good predictive performance were constructed and validated. Preoperative low-risk (T1-2N0M0) patients with age younger than 40 years, male gender, large tumor size, low FT4 and palpable nodes may be at high risk of LLNM or more than 5 CLNM, and they should receive more aggressive initial therapy to reduce CTx.
引用
收藏
页码:1395 / 1404
页数:10
相关论文
共 50 条
  • [21] A nomogram for enhanced risk stratification for predicting cervical lymph node metastasis in papillary thyroid carcinoma patients
    Deng, Lingxin
    Muhanhali, Dilidaer
    Ai, Zhilong
    Zhang, Min
    Ling, Yan
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [22] Nomograms based on preoperative multimodal ultrasound of papillary thyroid carcinoma for predicting central lymph node metastasis
    Quan Dai
    Dongmei Liu
    Yi Tao
    Chao Ding
    Shouqiang Li
    Chen Zhao
    Zhuo Wang
    Yangyang Tao
    Jiawei Tian
    Xiaoping Leng
    European Radiology, 2022, 32 : 4596 - 4608
  • [23] Construction and validation of a nomogram for predicting lateral lymph node metastasis in pediatric and adolescent with differentiated thyroid carcinoma
    Dan, Jiaqiang
    Tan, Jingya
    Guo, Yao
    Xu, Yang
    Zhou, Lin
    Huang, Junhua
    Yuan, Zhiying
    Ai, Xiang
    Li, Junyan
    ENDOCRINE, 2024, 85 (01) : 196 - 205
  • [24] Construction and validation of a nomogram for predicting cervical lymph node metastasis in diffuse sclerosing variant of papillary thyroid carcinoma
    Xunyi Lin
    Jiaxing Huo
    Huan Zhang
    Hang Su
    Fenghua Zhang
    Langenbeck's Archives of Surgery, 409
  • [25] Risk Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Retrospective Study
    Gong, Jiantao
    Zhu, Baining
    Liu, Wenji
    Shi, Chaoqun
    Xia, Chen
    Zeng, Liqin
    Lv, Yunxia
    HORMONE AND METABOLIC RESEARCH, 2023, 55 (05) : 315 - 322
  • [26] Screening and validation of lymph node metastasis risk-factor genes in papillary thyroid carcinoma
    Zhang, Qiaoyue
    Li, Jing
    Shen, Hengyan
    Bai, Xinyu
    Zhang, Tao
    Liu, Ping
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [27] Risk factors for the lateral cervical lymph node metastasis of papillary thyroid carcinoma: A clinical study
    Masui, Takashi
    Adachi, Shiori
    Uemura, Hirokazu
    Kimura, Takahiro
    Kitahara, Tadashi
    MOLECULAR AND CLINICAL ONCOLOGY, 2023, 18 (04)
  • [28] Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma
    Hu, Daixing
    Zhou, Jing
    He, Wei
    Peng, Jie
    Cao, Yijia
    Ren, Haoyu
    Mao, Yu
    Dou, Yi
    Xiong, Wei
    Xiao, Qi
    Su, Xinliang
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
  • [29] Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients
    Liu, Chenxi
    Xiao, Cheng
    Chen, Jianjia
    Li, Xiangyang
    Feng, Zijian
    Gao, Qiyuan
    Liu, Zhen
    BMC CANCER, 2019, 19 (1)
  • [30] Risk factors of central lymph node metastasis in papillary thyroid carcinoma: A retrospective cohort study
    Tang, Tong
    Li, Jia
    Zheng, Lu
    Zhang, Lei
    Shi, Jianing
    INTERNATIONAL JOURNAL OF SURGERY, 2018, 54 : 129 - 132